These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

880 related items for PubMed ID: 31754293

  • 1. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN, Mohamed MA, Madkour MA, Shamseya MM, Issa NM, Badr AN, Ghareeb DA, Pan CH.
    World J Gastroenterol; 2019 Nov 14; 25(42):6322-6341. PubMed ID: 31754293
    [Abstract] [Full Text] [Related]

  • 2. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
    Li J, Jin B, Wang T, Li W, Wang Z, Zhang H, Song Y, Li N.
    Cancer Biomark; 2019 Nov 14; 26(4):501-512. PubMed ID: 31658041
    [Abstract] [Full Text] [Related]

  • 3. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN, Youssef AS, El-Desouky ED, Ahmed OS, Lotfy MM, Nassar AA, Bahnassey AA.
    Tumour Biol; 2016 Sep 14; 37(9):12273-12286. PubMed ID: 27271989
    [Abstract] [Full Text] [Related]

  • 4. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
    Jin Y, Wong YS, Goh BKP, Chan CY, Cheow PC, Chow PKH, Lim TKH, Goh GBB, Krishnamoorthy TL, Kumar R, Ng TP, Chong SS, Tan HH, Chung AYF, Ooi LLPJ, Chang JPE, Tan CK, Lee CGL.
    Sci Rep; 2019 Jul 18; 9(1):10464. PubMed ID: 31320713
    [Abstract] [Full Text] [Related]

  • 5. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
    Giray BG, Emekdas G, Tezcan S, Ulger M, Serin MS, Sezgin O, Altintas E, Tiftik EN.
    Mol Biol Rep; 2014 Jul 18; 41(7):4513-9. PubMed ID: 24595450
    [Abstract] [Full Text] [Related]

  • 6. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ, Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L, Chen YP.
    Oncotarget; 2015 Sep 22; 6(28):25093-108. PubMed ID: 26231037
    [Abstract] [Full Text] [Related]

  • 7. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    Tat Trung N, Duong DC, Tong HV, Hien TTT, Hoan PQ, Bang MH, Binh MT, Ky TD, Tung NL, Thinh NT, Sang VV, Thao LTP, Bock CT, Velavan TP, Meyer CG, Song LH, Toan NL.
    PLoS One; 2018 Sep 22; 13(4):e0196081. PubMed ID: 29672637
    [Abstract] [Full Text] [Related]

  • 8. Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma.
    Wang Y, Zhang C, Zhang P, Guo G, Jiang T, Zhao X, Jiang J, Huang X, Tong H, Tian Y.
    Cancer Med; 2018 May 22; 7(5):1670-1679. PubMed ID: 29573235
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
    Pratedrat P, Chuaypen N, Nimsamer P, Payungporn S, Pinjaroen N, Sirichindakul B, Tangkijvanich P.
    PLoS One; 2020 May 22; 15(4):e0232211. PubMed ID: 32330203
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M, Kong X, Wang H, Huang G, Ye C, He Z.
    Oncotarget; 2017 Jan 31; 8(5):8775-8784. PubMed ID: 28060739
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH, Zayed N, Riad NM, Tamim HH, Shahin RMH, Labib DA, ELsheikh SM, Moneim RA, Yosry A, Khalifa RH.
    Virus Res; 2018 Aug 15; 255():77-84. PubMed ID: 30003924
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Circulating miRNA-199a and miRNA-122 Levels as Potential Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma.
    Wu J, Wu Y, Luo Y, Li X, Lin N, Yang X, Lin Y, Chen M.
    Ann Clin Lab Sci; 2020 Mar 15; 50(2):219-227. PubMed ID: 32366560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.